Damaris Diaz
Translational Genomics Research Institute(US)
Publications by Year
Research Areas
Malaria Research and Control, Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, Computational Drug Discovery Methods, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes(2017)64 cited
- → Tetraoxane Antimalarials and Their Reaction with Fe(II)(2006)52 cited
- → In vitro and in vivo efficacy and in vitro metabolism of 1-phenyl-3-aryl-2-propen-1-ones against Plasmodium falciparum(2006)27 cited
- → In Vitro Metabolism of Phenoxypropoxybiguanide Analogues in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines(2005)27 cited
- → Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys(2015)16 cited
- → Triazoles as γ-secretase modulators(2011)14 cited
- → Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate JPC2056 in cynomolgus monkeys using an in vivo in vitro model(2007)14 cited
- → The Role of In Vitro ADME Assays in Antimalarial Drug Discovery and Development(2005)14 cited
- → Potent benzoazepinone γ-secretase modulators with improved bioavailability(2015)13 cited
- → LP‐925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2(2015)13 cited